Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Circulating Tumor DNA Is Key Clue to Breast Cancer Spread
As a biomarker, it bests CA 15-3 in detecting metastasis and measuring treatment response
This article is older than one year and is no longer available.

Copyright © 2013 HealthDay. All rights reserved.

July 29, 2015

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

Patients Report Improved Care Access, Better Health With ACA

ASCO Calls for Cancer Trials to Include More Seniors

Mortality, Hospital Stays, Costs All Down Among U.S. Seniors

Not Resecting Ideal Candidates Ups Mortality in Liver Cancer

Atorvastatin/Ezetimibe Beats Atorvastatin After PCI

35% of Colorectal Cancers in Patients Age ≤35 Are Genetic